NEKTAR THERAPEUTICS — Director's Dealing 2018

Aug 16, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2018-08-13

Reporting Person: WINGER DENNIS L (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-13	Common Stock	S	17125	$61.04	Disposed	59875	Direct
2018-08-14	Common Stock	S	17125	$60.15	Disposed	42750	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5000	Indirect

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $61.03 to $61.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

F2: This transaction was executed in multiple trades at prices ranging from $60.09 to $60.27. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.